Yuji Otsuki1, Hiroaki Kuwahara2, Hirofumi Konn3. 1. Department of Thoracic Surgery, KKR Sapporo Medical Center, 6-3-40, Hiragishi 1-jo, Toyohira-ku Sapporo-shi, Hokkaido, 062-0931, Japan. uzotk0128@gmail.com. 2. Department of Thoracic Surgery, KKR Sapporo Medical Center, 6-3-40, Hiragishi 1-jo, Toyohira-ku Sapporo-shi, Hokkaido, 062-0931, Japan. 3. Department of Dialysis, KKR Sapporo Medical Center, 6-3-40, Hiragishi 1-jo, Toyohira-ku Sapporo-shi, Hokkaido, 062-0931, Japan.
Abstract
OBJECTIVE: The rate of surgical resection of lung cancer in patients on hemodialysis is expected to increase due to the development of hemodialysis, improved diagnosis of lung cancer, and increases in the number and age of patients. However, studies assessing outcomes of lung resection in these patients are limited. In this retrospective case series, we investigated the safety and efficacy of video-assisted thoracic surgery (VATS) for lobectomy or segmentectomy for lung cancer in patients on hemodialysis. METHODS: Between January 2010 and January 2017, lobectomy or segmentectomy using VATS was performed for seven lung cancer cases in six patients receiving hemodialysis at our institution. There were two female and five male patients, with a median age of 61 years (range 53-76 years). Six patients underwent lobectomy, and segmentectomy and wedge resection were performed in each one case, respectively; systematic mediastinal lymph node dissection (ND2a-2) was performed in six patients. RESULTS: There were no perioperative deaths in this case series. Median recurrence-free and overall survival rates were 20 months (range 3-82 months) and 31 months (range 3-82 months), respectively. CONCLUSIONS: Video-assisted thoracic surgery (VATS) is a safe and effective procedure for resection of lung cancer in hemodialysis patients and should be considered after accurate determination of surgical indications and careful perioperative management.
OBJECTIVE: The rate of surgical resection of lung cancer in patients on hemodialysis is expected to increase due to the development of hemodialysis, improved diagnosis of lung cancer, and increases in the number and age of patients. However, studies assessing outcomes of lung resection in these patients are limited. In this retrospective case series, we investigated the safety and efficacy of video-assisted thoracic surgery (VATS) for lobectomy or segmentectomy for lung cancer in patients on hemodialysis. METHODS: Between January 2010 and January 2017, lobectomy or segmentectomy using VATS was performed for seven lung cancer cases in six patients receiving hemodialysis at our institution. There were two female and five male patients, with a median age of 61 years (range 53-76 years). Six patients underwent lobectomy, and segmentectomy and wedge resection were performed in each one case, respectively; systematic mediastinal lymph node dissection (ND2a-2) was performed in six patients. RESULTS: There were no perioperative deaths in this case series. Median recurrence-free and overall survival rates were 20 months (range 3-82 months) and 31 months (range 3-82 months), respectively. CONCLUSIONS: Video-assisted thoracic surgery (VATS) is a safe and effective procedure for resection of lung cancer in hemodialysis patients and should be considered after accurate determination of surgical indications and careful perioperative management.
Entities:
Keywords:
Hemodialysis; Lung cancer; Video-assisted thoracic surgery
Authors: Walter J Scott; Mark S Allen; Gail Darling; Bryan Meyers; Paul A Decker; Joe B Putnam; Robert W McKenna; Rodney J Landrenau; David R Jones; Richard I Inculet; Richard A Malthaner Journal: J Thorac Cardiovasc Surg Date: 2010-02-20 Impact factor: 5.209
Authors: M Diaz-Ricart; E Etebanell; A Cases; J López-Pedret; R Castillo; A Ordinas; G Escolar Journal: Thromb Haemost Date: 1999-10 Impact factor: 5.249
Authors: P Maisonneuve; L Agodoa; R Gellert; J H Stewart; G Buccianti; A B Lowenfels; R A Wolfe; E Jones; A P Disney; D Briggs; M McCredie; P Boyle Journal: Lancet Date: 1999-07-10 Impact factor: 79.321
Authors: Christopher R Schneider; William Cobb; Shivani Patel; David Cull; Cass Anna; Richard Roettger Journal: Am Surg Date: 2009-09 Impact factor: 0.688